Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Study Evaluating Efficacy and Safety of OSU6162 in the Treatment of Residual Symptoms After Stroke
- First Posted Date
- 2019-10-15
- Last Posted Date
- 2020-10-01
- Lead Sponsor
- Arvid Carlsson Research AB
- Target Recruit Count
- 101
- Registration Number
- NCT04127669
- Locations
- 🇸🇪
Gottfries Clinic AB, Gothenburg, Sweden
News
No news found